Clincosm LogoSign in Get a demo

Mantle Cell Lymphoma

Showing 1 - 25 of 208
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mature B-Cell Tumor, Non Hodgkin Lymphoma, DLBCL Trial (SGR-1505)

Not yet recruiting
  • Mature B-Cell Neoplasm
  • +25 more
  • (no location specified)
Sep 14, 2022

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in New York (Ibrutinib, Pembrolizumab)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Mantle Cell Lymphoma
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Aug 22, 2022

Mantle Cell Lymphoma Trial in Houston (Acalabrutinib)

Recruiting
  • Mantle Cell Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Aug 22, 2022

Mantle Cell Lymphoma Trial in United States (Acalabrutinib, Bortezomib, Cyclophosphamide)

Recruiting
  • Mantle Cell Lymphoma
  • New Orleans, Louisiana
  • +5 more
Aug 23, 2022

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in Spokane, Salamanca (Zilovertamab vedotin,

Recruiting
  • Chronic Lymphocytic Leukemia
  • +3 more
  • Spokane, Washington
  • +1 more
Aug 12, 2022

B-Cell Lymphoma, B Acute Lymphoblastic Leukemia, Diffuse Large B Cell Lymphoma Trial in Pittsburgh (Chimeric Antigen Receptor

Recruiting
  • B-Cell Lymphoma
  • +8 more
  • Chimeric Antigen Receptor (CAR) T-Cell Product (Autologous)
  • Pittsburgh, Pennsylvania
    AHN Cancer Institute - West Penn Hospital
Aug 10, 2022

Lymphoma, Mantle Cell Lymphoma Trial in Houston (Acalabrutinib, Rituximab, Brexucabtagene Autoleucel)

Not yet recruiting
  • Lymphoma
  • Mantle Cell Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Aug 10, 2022

Mantle Cell Lymphoma, Refractory Lymphoma Trial in Boston (Acalabrutinib, Venetoclax, Obinutuzumab)

Recruiting
  • Mantle Cell Lymphoma
  • Refractory Lymphoma
  • Boston, Massachusetts
  • +1 more
Aug 8, 2022

Recurrent Refractory Mantle Cell Lymphoma

Recruiting
  • Mantle Cell Lymphoma
    • Beijing, Beijing, China
      Peking University Third Hospital
    Aug 1, 2022

    Asymptomatic COVID-19 Infection Laboratory-Confirmed, B-Cell Tumor, Chronic Lymphocytic Leukemia Trial in Rochester (Ibrutinib,

    Withdrawn
    • Asymptomatic COVID-19 Infection Laboratory-Confirmed
    • +8 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Aug 2, 2022

    Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma (MCL), Relapsed Mantle Cell Lymphoma Trial (BGB-11417)

    Not yet recruiting
    • Mantle Cell Lymphoma
    • +2 more
    • (no location specified)
    Jul 25, 2022

    B-cell Malignancy, Low-grade, Non-Hodgkin Lymphoma, Mantle Cell Lymphoma Trial in China (BGB-16673)

    Recruiting
    • B-cell Malignancy, Low-grade
    • +4 more
    • Beijing, Beijing, China
    • +8 more
    Jul 20, 2022

    Follicular Lymphoma, Marginal Zone Lymphoma, Mantle Cell Lymphoma Trial run by the NCI (Obinutuzumab, Venetoclax, Magrolimab)

    Recruiting
    • Follicular Lymphoma
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jul 20, 2022

    Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma, Follicular Lymphoma Trial in Hangzhou (RD14-01 cell infusion)

    Recruiting
    • Mantle Cell Lymphoma
    • +2 more
    • RD14-01 cell infusion
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital, College of Medicine, Zhejiang Uni
    Jul 6, 2022

    Mantle Cell Lymphoma Trial in China (ICP-022)

    Active, not recruiting
    • Mantle Cell Lymphoma
    • Hefei, Anhui, China
    • +30 more
    Jul 5, 2022

    B-Cell Non-Hodgkin Lymphoma, DLBCL, Mantle Cell Lymphoma Trial in Duarte (Anti-CD19-CAR CMV-specific T-lymphocytes, Autologous

    Not yet recruiting
    • B-Cell Non-Hodgkin Lymphoma
    • +7 more
    • Anti-CD19-CAR CMV-specific T-lymphocytes
    • +3 more
    • Duarte, California
      City of Hope Medical Center
    Jun 28, 2022

    Mantle Cell Lymphoma Trial in Baltimore (Venetoclax Oral Tablet [Venclexta])

    Recruiting
    • Mantle Cell Lymphoma
    • Venetoclax Oral Tablet [Venclexta]
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Jun 29, 2022

    Mantle Cell Lymphoma Trial in Beijing

    Recruiting
    • Mantle Cell Lymphoma
      • Beijing, Beijing, China
        Hongmei Third Jing
      Jun 20, 2022

      Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma Trial in Palo Alto (Ibrutinib, Radiation

      Active, not recruiting
      • Grade 1 Follicular Lymphoma
      • +6 more
      • Palo Alto, California
        Stanford University, School of Medicine
      Jun 13, 2022

      Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma Trial in United States (Buparlisib, Ibrutinib)

      Active, not recruiting
      • Lymphoma
      • +3 more
      • Basking Ridge, New Jersey
      • +5 more
      Jun 13, 2022

      Mantle Cell Lymphoma Trial in Duarte (Acalabrutinib, Ublituximab, Umbralisib)

      Suspended
      • Mantle Cell Lymphoma
      • Duarte, California
        City of Hope Medical Center
      Jun 7, 2022

      The Role of 18F-FDG-PET for Staging and Prognostication

      Recruiting
      • Mantle Cell Lymphoma
        • Reggio Calabria, Calabria, Italy
        • +30 more
        Jun 8, 2022

        Mantle Cell Lymphoma Trial in Duarte, Ann Arbor, Columbus (Venetoclax, Lenalidomide, Rituximab)

        Active, not recruiting
        • Mantle Cell Lymphoma
        • Duarte, California
        • +2 more
        May 17, 2022

        B-cell Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory Trial in Taipei (RPM

        Terminated
        • B-cell Acute Lymphoblastic Leukemia
        • +7 more
        • RPM CD19-mbIL15-CAR-T cells
        • Taipei, Taiwan
          National Taiwan University Hospital
        May 11, 2022

        CLL/SLL, Waldenstrom Macroglobulinemia, Follicular Lymphoma Trial in Cincinnati, Columbus, Salt Lake City (LP-168)

        Recruiting
        • CLL/SLL
        • +6 more
        • Cincinnati, Ohio
        • +2 more
        May 7, 2022